Business
Press Release Nov 09 2020
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 09, 2020, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval for Palbociclib Capsules, 75 mg, 100 mg, and 125 mg.".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 09, 2020, titled \"Alembic Pharmaceuticals receives USFDA Tentative Approval for Palbociclib Capsules, 75 mg, 100 mg, and 125 mg.\". View Attachment","length":405,"tagName":"div"}]